Form 4: Outset Medical CEO Executes Sell-to-Cover Transaction

Outset Medical CEO Leslie Trigg sold 3,445 shares of common stock to satisfy tax withholding obligations related to RSU vesting.

Summary

• Leslie Trigg, Chair and CEO of Outset Medical, sold 3,445 shares of common stock on May 15, 2026.
• The transaction was executed at a price of $3.70 per share.
• The sale was a mandatory 'sell-to-cover' transaction to satisfy tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• The filing includes a correction to a previously reported transaction from February 19, 2026, adjusting the share count for tax withholding purposes.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax obligations rather than a discretionary sale of stock.

Positives

• The transaction was non-discretionary, indicating it was not a signal of management's view on the company's future performance.

Negatives

• The filing notes an administrative error in a previous Form 4 filing regarding the number of shares sold for tax purposes.

Risks

• Continued reliance on equity-based compensation may lead to periodic sell-to-cover transactions that impact share liquidity.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Management Comments

• The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.

Industry Context

StockSavvy.ai notes that 'sell-to-cover' transactions are standard corporate governance procedures for executives receiving equity compensation and generally do not reflect changes in management sentiment regarding company health.

Comparison to Industry Standards

• The use of 'sell-to-cover' transactions is a standard practice across the medical device and broader healthcare sector for executive compensation tax compliance.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was non-discretionary and limited in volume.

Next Steps

• None mentioned.

Key Dates

Keywords

Outset Medical, OM, Insider Trading, Form 4, Leslie Trigg, Medical Devices